Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea--a report from the Korean Breast Cancer Society.
about
Managing breast cancer in younger women: challenges and solutionsChemotherapy in Premenopausal Breast Cancer PatientsUnique features of young age breast cancer and its managementIdentification of inherited genetic variations influencing prognosis in early-onset breast cancerUltrasound and clinicopathological characteristics of triple receptor-negative breast cancers.Retrospective analysis of clinicopathological characteristics and family history data of early-onset breast cancer: a single-institutional study of Hungarian patients.Characteristics of BRCA1/2 Mutation-Positive Breast Cancers in Korea: A Comparison Study Based on Multicenter Data and the Korean Breast Cancer Registry.Breast cancer in young women: poor survival despite intensive treatment.Outcome after neoadjuvant chemotherapy in young breast cancer patients: a pooled analysis of individual patient data from eight prospectively randomized controlled trials.Young Age Is Associated with Increased Locoregional Recurrence in Node-Positive Breast Cancer with Luminal Subtypes.Triple negativity and young age as prognostic factors in lymph node-negative invasive ductal carcinoma of 1 cm or less.A comparison of survival outcomes and side effects of toremifene or tamoxifen therapy in premenopausal estrogen and progesterone receptor positive breast cancer patients: a retrospective cohort studyEffects of interval between age at first pregnancy and age at diagnosis on breast cancer survival according to menopausal status: a register-based study in KoreaBody mass index is not associated with treatment outcomes of breast cancer patients receiving neoadjuvant chemotherapy: korean data.An evaluation of the prognostic model PREDICT using the POSH cohort of women aged ⩽40 years at breast cancer diagnosis.Survival Improvement in Korean Breast Cancer Patients Due to Increases in Early-Stage Cancers and Hormone Receptor Positive/HER2 Negative Subtypes: A Nationwide Registry-Based StudyImpact of established prognostic factors and molecular subtype in very young breast cancer patients: pooled analysis of four EORTC randomized controlled trialsClinical Significance of Age at the Time of Diagnosis among Young Breast Cancer Patients.Molecular Phenotype of Breast Cancer According to Time Since Last Pregnancy in a Large Cohort of Young Women.Ovarian Function, Not Age, Predicts the Benefit from Ovarian Suppression or Ablation for Premenopausal Women with Breast Cancer.Characterization of molecular subtypes of Korean breast cancer: an ethnically and clinically distinct populationThe role of the addition of ovarian suppression to tamoxifen in young women with hormone-sensitive breast cancer who remain premenopausal or regain menstruation after chemotherapy (ASTRRA): study protocol for a randomized controlled trial and progreThe effect of age on delay in diagnosis and stage of breast cancerTumour biomarker expression relative to age and molecular subtypes of invasive breast cancer.Evaluation of the Survival Benefit of Different Chemotherapy Regimens in Patients with T1-2N0 Triple-Negative Breast Cancer.Age at diagnosis and breast cancer survival in iran.Different Expression of Extracellular Signal-Regulated Kinases (ERK) 1/2 and Phospho-Erk Proteins in MBA-MB-231 and MCF-7 Cells after Chemotherapy with Doxorubicin or DocetaxelThe prognostic value of age for invasive lobular breast cancer depending on estrogen receptor and progesterone receptor-defined subtypes: A NCDB analysisTrends in the Application of Postmastectomy Radiotherapy for Breast Cancer With 1 to 3 Positive Axillary Nodes and Tumors ≤5 cm in the Modern Treatment Era: A Retrospective Korean Breast Cancer Society ReportCumulative survival in early-onset unilateral and bilateral breast cancer: an analysis of 1907 Taiwanese womenClinical relevance of lymph node ratio in breast cancer patients with one to three positive lymph nodes.Prognostic Effects of Adjuvant Chemotherapy-Induced Amenorrhea and Subsequent Resumption of Menstruation for Premenopausal Breast Cancer Patients.Association of Human Epidermal Growth Factor Receptor 2 with Radiotherapy Resistance in Patients with T1N0M0 Breast Cancer.Young adult breast cancer patients have a poor prognosis independent of prognostic clinicopathological factors: a study from the Japanese Breast Cancer Registry.Long-term outcome in young women with breast cancer: a population-based study.Reproductive factors and risk of premenopausal breast cancer by age at diagnosis: are there differences before and after age 40?Effect Modification of Hormonal Therapy by p53 Status in Invasive Breast Cancer.Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer.Hormonal therapy in breast cancer: a model disease for the personalization of cancer care.Breast cancer presentation and diagnostic delays in young women.
P2860
Q26771184-0003069A-B8B6-40E6-AD36-87E48BC29BD2Q26774622-DFC57BD1-A7BF-401F-B6ED-7835E794C23AQ26821902-F3C83FCD-81D2-4919-9D37-C3FB3F6B78F4Q28943279-F5E16B94-975E-4D26-AF37-C6140D35B097Q30474511-2AFBF252-4F90-4C50-B28B-2818615DD54DQ30633035-673397D6-91F4-49BF-8531-B74E146FF7E1Q30836057-6E9DAECF-D587-4F07-B3AA-E83B42CA15F6Q30882889-80EDEDE7-4314-4B1B-AE9E-5795E016DBE2Q30976616-FAFCD35A-BF72-4C83-A9EE-809F991B218EQ33584079-7DA6D889-60AA-4F05-AA0B-C32137470D5BQ33718750-BF9D2C94-F5BE-4A3C-AC69-41B20074ADDBQ34252972-7A633A54-7DB9-4CD8-AA67-D2E277795860Q34267427-393FD9CE-084B-4EB3-8ADB-73054E26538CQ34560725-DEE2FE70-3C84-451A-AEC8-ED567E9D2608Q35198352-D98DC03B-DBF9-43B1-B373-2AAE33F1EEB0Q35237226-BD61CAC3-A45E-4FE1-A3FE-328862A15902Q35558130-23FDDD4F-BDAF-4638-A88C-7EA03660A8BFQ35713872-EC568BA2-1BC5-4859-8E5C-3C35B36CFD9BQ35820514-6621E45B-8012-43AC-8E75-EBE35130A768Q35920776-79F5BB0D-3A96-4FFD-9746-B6DE636AEE28Q36006125-69E50EBB-400B-44FC-8606-5704D773F5EBQ36022957-0AAD9CD7-57E5-4923-8B0E-B54C89CDE31FQ36051489-545A01CA-54B3-4A79-A1BF-A701C8F92C74Q36089922-5462A664-BED7-4FC4-9B4C-E0F605D4F30DQ36145737-217CFC7A-E9D9-43E4-AEED-E4DBF7CC82B1Q36440147-5C6956C8-E7FC-4437-BE50-C23150150FA9Q36652542-BB1FD97C-B3DC-4B51-A572-10B7325B417CQ36905846-C490E00A-9184-419D-9558-F16E475A2DA7Q36993433-EE0CCD9E-08EA-4975-812B-513AAD7EC3E5Q37123440-4BD11E22-A8D9-4556-95BB-F252BFF775D6Q37185862-B6C80204-AF4B-4183-9206-1E6C0F31F876Q37206820-A2500E28-6243-4BDF-970B-9FE0F86800B6Q37240029-BFC2A86C-A401-4880-8704-ABFF93F061ADQ37310103-E14DD544-2BE8-451B-B4F8-32B3176D4A10Q37310148-F82E71D6-3333-43B3-8EA5-0F20C0C013B1Q37362781-64BAD93B-0B41-4A69-A437-FF41D749691FQ37484645-27193208-0F6C-4AFD-93B9-9CD1181619AFQ37955652-F4D18D5D-3433-443E-BA7A-DF7DA0B3B322Q37992403-7D4A7544-28BC-423D-8F5E-9EBAA647B543Q38172058-8A9CAD8E-FF44-40F3-9CF2-2A41C3A5220C
P2860
Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea--a report from the Korean Breast Cancer Society.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Poor outcome of hormone recept ...... Korean Breast Cancer Society.
@ast
Poor outcome of hormone recept ...... Korean Breast Cancer Society.
@en
type
label
Poor outcome of hormone recept ...... Korean Breast Cancer Society.
@ast
Poor outcome of hormone recept ...... Korean Breast Cancer Society.
@en
prefLabel
Poor outcome of hormone recept ...... Korean Breast Cancer Society.
@ast
Poor outcome of hormone recept ...... Korean Breast Cancer Society.
@en
P2093
P356
P1476
Poor outcome of hormone recept ...... Korean Breast Cancer Society.
@en
P2093
Byung Ho Son
Korean Breast Cancer Society
Sei Hyun Ahn
Seok Won Kim
Seung Il Kim
Seung-Sang Ko
Wonshik Han
P304
P356
10.1200/JCO.2006.10.3754
P407
P50
P577
2007-05-21T00:00:00Z